America First Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-301
Closed -$230K 43
2025
Q3
$230K Hold
301
0.04% 42
2025
Q2
$235K Hold
301
0.05% 42
2025
Q1
$249K Hold
301
0.05% 38
2024
Q4
$232K Hold
301
0.05% 41
2024
Q3
$267K Hold
301
0.06% 39
2024
Q2
$273K Hold
301
0.07% 39
2024
Q1
$234K Hold
301
0.06% 38
2023
Q4
$175K Hold
301
0.05% 40
2023
Q3
$162K Hold
301
0.04% 41
2023
Q2
$141K Hold
301
0.04% 42
2023
Q1
$103K Buy
+301
New +$102K 0.03% 44
2017
Q2
Sell
-150
Closed -$13K 125
2017
Q1
$13K Buy
+150
New +$12K ﹤0.01% 118

Other funds holding LLY

America First Investment Advisors's LLY Position: Q4 2025 in Review

America First Investment Advisors sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 301 shares — an estimated $230K sold.

America First Investment Advisors first reported a position in LLY in Q1 2017 and held it in 12 quarters. The position peaked at $273K in Q2 2024. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • America First Investment Advisors reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • America First Investment Advisors sold 301 Eli Lilly shares in Q4 2025, an estimated $230K.
  • America First Investment Advisors first reported a position in Eli Lilly in Q1 2017 and held it in 12 quarters.
  • America First Investment Advisors's Eli Lilly position peaked at $273K in Q2 2024.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on America First Investment Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.